Neurology

Ovid, UConn collaborating on genetic therapy for Angelman syndrome

Ovid Therapeutics Inc and the University of Connecticut School of Medicine (UConn), announced a research collaboration and license agreement to accelerate the development of a next-generation short hairpin RNA (shRNA)-based therapeutic for Angelman syndrome, according to a press release. One of the most common causes of Angelman syndrome is the...